<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Cancer / Virotherapy / Biotechnology / Experimental cancer treatments / Antineoplastic drugs / Cancer treatments / Melanoma / Oncolytic virus / Oncolytic herpes virus / Ipilimumab
Date: 2016-03-02 10:23:54
Medicine
Clinical medicine
Cancer
Virotherapy
Biotechnology
Experimental cancer treatments
Antineoplastic drugs
Cancer treatments
Melanoma
Oncolytic virus
Oncolytic herpes virus
Ipilimumab

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

Add to Reading List

Source URL: moffitt.org

Download Document from Source Website

File Size: 423,20 KB

Share Document on Facebook

Similar Documents

Exotic Newcastle Disease in Florida  In the second week of January, a case of Exotic Newcastle Disease (END) was diagnosed in cormorants in Pinellas County, Florida. END is relatively common among cormorants. Usually, th

Exotic Newcastle Disease in Florida In the second week of January, a case of Exotic Newcastle Disease (END) was diagnosed in cormorants in Pinellas County, Florida. END is relatively common among cormorants. Usually, th

DocID: 1rtKd - View Document

VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01 Basel (Switzerland) and Mannheim (Germany), July 12, 2016 – VAXIMM AG, a Swiss/German biotech company focused on develo

VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01 Basel (Switzerland) and Mannheim (Germany), July 12, 2016 – VAXIMM AG, a Swiss/German biotech company focused on develo

DocID: 1rgZo - View Document

When Patients Win, We All Win™  Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation

When Patients Win, We All Win™ Provectus Biopharmaceuticals, Inc Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus’ investigation

DocID: 1rgN5 - View Document

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile.  Photo courtesy of Dina Potter. Sunny Tree. 48

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

DocID: 1rePY - View Document

MIT Committee on Assessment of Biohazards: Policy for Use of Lentiviral Vectors

MIT Committee on Assessment of Biohazards: Policy for Use of Lentiviral Vectors

DocID: 1r6Cz - View Document